questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Structures de chromosome
Chromatides
Chromatides : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Immunofluorescence
Protéines
Microscopie électronique
Chromatides
Symptômes
5
Anomalies chromosomiques
Malformations congénitales
Syndrome de Down
Maladies génétiques
Cancers
Troubles génétiques
Traits faciaux
Troubles chromosomiques
Fertilité
Anomalies chromosomiques
Prévention
5
Conseils génétiques
Suivi prénatal
Alimentation
Acide folique
Tests génétiques
Anomalies chromosomiques
Vaccination
Développement fœtal
Suivi médical
Anomalies chromosomiques
Traitements
5
Thérapie génique
Interventions chirurgicales
Syndrome de Turner
Traitements hormonaux
Chirurgie
Anomalies chromosomiques
Thérapie génique
Anomalies chromosomiques
Complications
5
Troubles du développement
Cancers
Complications chroniques
Qualité de vie
Santé mentale
Troubles mentaux
Complications
Gestion des symptômes
Maladies auto-immunes
Anomalies chromosomiques
Facteurs de risque
5
Âge maternel
Antécédents familiaux
Radiations
Anomalies chromosomiques
Facteurs génétiques
Anomalies chromosomiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chromatides : Questions médicales les plus fréquentes",
"headline": "Chromatides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chromatides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chromatides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures de chromosome",
"url": "https://questionsmedicales.fr/mesh/D022004",
"about": {
"@type": "MedicalCondition",
"name": "Structures de chromosome",
"code": {
"@type": "MedicalCode",
"code": "D022004",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.160"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chromatides",
"alternateName": "Chromatids",
"code": {
"@type": "MedicalCode",
"code": "D002842",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Job de Lange",
"url": "https://questionsmedicales.fr/author/Job%20de%20Lange",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Genetics, Section Oncogenetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands j.delange1@amsterdamumc.nl."
}
},
{
"@type": "Person",
"name": "Daniel W Gerlich",
"url": "https://questionsmedicales.fr/author/Daniel%20W%20Gerlich",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter, Vienna, Austria. daniel.gerlich@imba.oeaw.ac.at."
}
},
{
"@type": "Person",
"name": "Martin A Rooimans",
"url": "https://questionsmedicales.fr/author/Martin%20A%20Rooimans",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Genetics, Section Oncogenetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands."
}
},
{
"@type": "Person",
"name": "Janne J M van Schie",
"url": "https://questionsmedicales.fr/author/Janne%20J%20M%20van%20Schie",
"affiliation": {
"@type": "Organization",
"name": "Cancer Center Amsterdam, Department of Clinical Genetics, section Oncogenetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands."
}
},
{
"@type": "Person",
"name": "Jesper A Balk",
"url": "https://questionsmedicales.fr/author/Jesper%20A%20Balk",
"affiliation": {
"@type": "Organization",
"name": "Cancer Center Amsterdam, Department of Clinical Genetics, section Oncogenetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinical Pharmacokinetics and Pharmacodynamics of Cefepime.",
"datePublished": "2022-06-29",
"url": "https://questionsmedicales.fr/article/35764774",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40262-022-01137-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae.",
"datePublished": "2023-02-18",
"url": "https://questionsmedicales.fr/article/36804369",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijantimicag.2023.106762"
}
},
{
"@type": "ScholarlyArticle",
"name": "Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/36401796",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/phar.2744"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cefepime-modified magnetic nanoparticles and enzymatic colorimetry for the detection of Listeria monocytogenes in lettuces.",
"datePublished": "2022-12-23",
"url": "https://questionsmedicales.fr/article/36586253",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodchem.2022.135296"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal function.",
"datePublished": "2022-05-20",
"url": "https://questionsmedicales.fr/article/35605841",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmi.2022.05.007"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Structures de chromosome",
"item": "https://questionsmedicales.fr/mesh/D022004"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chromatides",
"item": "https://questionsmedicales.fr/mesh/D002842"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chromatides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chromatides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chromatides",
"description": "Comment identifier les chromatides lors de la mitose ?\nQuels tests révèlent des anomalies des chromatides ?\nLes chromatides peuvent-elles être analysées par PCR ?\nQuel rôle joue l'immunofluorescence dans l'étude des chromatides ?\nPeut-on observer les chromatides en microscopie électronique ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Cefepime#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chromatides",
"description": "Quels symptômes indiquent des anomalies chromosomiques ?\nLes anomalies des chromatides causent-elles des maladies ?\nComment les anomalies des chromatides affectent-elles la santé ?\nLes symptômes des troubles chromosomiques sont-ils visibles à la naissance ?\nLes troubles des chromatides peuvent-ils affecter la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Cefepime#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chromatides",
"description": "Peut-on prévenir les anomalies chromosomiques ?\nQuel rôle joue l'alimentation dans la prévention des anomalies chromosomiques ?\nLes tests génétiques peuvent-ils aider à prévenir des anomalies ?\nLa vaccination peut-elle prévenir des anomalies chromosomiques ?\nLe suivi médical régulier aide-t-il à prévenir les anomalies chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Cefepime#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chromatides",
"description": "Quels traitements existent pour les anomalies chromosomiques ?\nLa chimiothérapie est-elle utilisée pour traiter des anomalies des chromatides ?\nLes traitements sont-ils disponibles pour le syndrome de Turner ?\nPeut-on corriger les anomalies chromosomiques par chirurgie ?\nLes thérapies géniques sont-elles efficaces contre les anomalies chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Cefepime#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chromatides",
"description": "Quelles complications peuvent résulter d'anomalies chromosomiques ?\nLes anomalies des chromatides peuvent-elles entraîner des complications à long terme ?\nComment les anomalies chromosomiques affectent-elles la santé mentale ?\nLes complications des anomalies chromosomiques sont-elles réversibles ?\nLes anomalies chromosomiques augmentent-elles le risque de maladies auto-immunes ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Cefepime#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chromatides",
"description": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?\nLes infections pendant la grossesse augmentent-elles les risques chromosomiques ?\nL'exposition aux radiations influence-t-elle les anomalies chromosomiques ?\nLe tabagisme maternel est-il un facteur de risque ?\nLes facteurs génétiques jouent-ils un rôle dans les anomalies chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002842?mesh_terms=Cefepime#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les chromatides lors de la mitose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les chromatides sont visibles sous un microscope lors de la métaphase de la mitose."
}
},
{
"@type": "Question",
"name": "Quels tests révèlent des anomalies des chromatides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses cytogénétiques, comme le caryotype, peuvent détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Les chromatides peuvent-elles être analysées par PCR ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut être utilisée pour analyser des segments spécifiques des chromatides."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'immunofluorescence dans l'étude des chromatides ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunofluorescence permet de visualiser des protéines spécifiques sur les chromatides."
}
},
{
"@type": "Question",
"name": "Peut-on observer les chromatides en microscopie électronique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la microscopie électronique offre une résolution élevée pour observer les chromatides."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent des anomalies chromosomiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies chromosomiques peuvent entraîner des malformations congénitales ou des troubles du développement."
}
},
{
"@type": "Question",
"name": "Les anomalies des chromatides causent-elles des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent être liées à des maladies comme le syndrome de Down."
}
},
{
"@type": "Question",
"name": "Comment les anomalies des chromatides affectent-elles la santé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des cancers ou des troubles génétiques héréditaires."
}
},
{
"@type": "Question",
"name": "Les symptômes des troubles chromosomiques sont-ils visibles à la naissance ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent être visibles à la naissance, comme des traits faciaux caractéristiques."
}
},
{
"@type": "Question",
"name": "Les troubles des chromatides peuvent-ils affecter la fertilité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies chromosomiques peuvent entraîner des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies chromosomiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être évitées par des conseils génétiques et un suivi prénatal."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention des anomalies chromosomiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en acide folique peut réduire le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à prévenir des anomalies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques permettent d'identifier les risques d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "La vaccination peut-elle prévenir des anomalies chromosomiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui pourraient affecter le développement fœtal."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier aide-t-il à prévenir les anomalies chromosomiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier peut aider à détecter et gérer les risques d'anomalies."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies chromosomiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements varient selon la condition, incluant thérapies géniques et interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle utilisée pour traiter des anomalies des chromatides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie peut être utilisée pour traiter certains cancers liés à des anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils disponibles pour le syndrome de Turner ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements hormonaux et des interventions médicales peuvent aider les patients."
}
},
{
"@type": "Question",
"name": "Peut-on corriger les anomalies chromosomiques par chirurgie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être corrigées par chirurgie, selon leur nature et gravité."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles efficaces contre les anomalies chromosomiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques montrent un potentiel prometteur pour certaines anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'anomalies chromosomiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles du développement, des malformations et des cancers."
}
},
{
"@type": "Question",
"name": "Les anomalies des chromatides peuvent-elles entraîner des complications à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent causer des complications chroniques et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment les anomalies chromosomiques affectent-elles la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des troubles mentaux ou des difficultés d'adaptation sociale."
}
},
{
"@type": "Question",
"name": "Les complications des anomalies chromosomiques sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup ne sont pas réversibles."
}
},
{
"@type": "Question",
"name": "Les anomalies chromosomiques augmentent-elles le risque de maladies auto-immunes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies chromosomiques peuvent être associées à un risque accru de maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge maternel avancé, des antécédents familiaux et certaines expositions environnementales."
}
},
{
"@type": "Question",
"name": "Les infections pendant la grossesse augmentent-elles les risques chromosomiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections comme la rubéole peuvent augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "L'exposition aux radiations influence-t-elle les anomalies chromosomiques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux radiations peut augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Le tabagisme maternel est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme pendant la grossesse est associé à un risque accru d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les facteurs génétiques jouent-ils un rôle dans les anomalies chromosomiques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations génétiques héréditaires peuvent augmenter le risque d'anomalies chromosomiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Human Genetics, Section Oncogenetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands j.delange1@amsterdamumc.nl.
Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, Netherlands.
Publications dans "Chromatides" :
4 publications dans cette catégorie
Affiliations :
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter, Vienna, Austria. daniel.gerlich@imba.oeaw.ac.at.
Publications dans "Chromatides" :
4 publications dans cette catégorie
Affiliations :
Department of Human Genetics, Section Oncogenetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, Netherlands.
Publications dans "Chromatides" :
4 publications dans cette catégorie
Affiliations :
Cancer Center Amsterdam, Department of Clinical Genetics, section Oncogenetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Publications dans "Chromatides" :
4 publications dans cette catégorie
Affiliations :
Cancer Center Amsterdam, Department of Clinical Genetics, section Oncogenetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Publications dans "Chromatides" :
4 publications dans cette catégorie
Affiliations :
Cancer Center Amsterdam, Department of Clinical Genetics, section Oncogenetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands. Electronic address: r.wolthuis@amsterdamumc.nl.
Publications dans "Chromatides" :
3 publications dans cette catégorie
Affiliations :
Centro Andaluz de Biología Molecular y Medicina Regenerativa, CABIMER, Universidad de Sevilla-CSIC-UPO, Seville, Spain. aguilo@us.es.
Publications dans "Chromatides" :
3 publications dans cette catégorie
Affiliations :
Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
Publications dans "Chromatides" :
3 publications dans cette catégorie
Affiliations :
Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
Publications dans "Chromatides" :
3 publications dans cette catégorie
Affiliations :
Chromosome Segregation Laboratory, The Francis Crick Institute, London NW1 1AT, UK. Electronic address: frank.uhlmann@crick.ac.uk.
Publications dans "Chromatides" :
3 publications dans cette catégorie
Affiliations :
Life Sciences Institute, State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of Zhejiang University School of Medicine, MOE Laboratory of Biosystems Homeostasis and Protection, Zhejiang University, Hangzhou, 310058, China. fwwang@zju.edu.cn.
Department of Gynecological Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China. fwwang@zju.edu.cn.
Cancer Center, Zhejiang University, Hangzhou, 310058, China. fwwang@zju.edu.cn.
Zhejiang Provincial Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China. fwwang@zju.edu.cn.
Publications dans "Chromatides" :
3 publications dans cette catégorie
Affiliations :
Cancer Center Amsterdam, Department of Clinical Genetics, section Oncogenetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Publications dans "Chromatides" :
2 publications dans cette catégorie
Affiliations :
Department of Environmental & Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA. Takamitsu.Kato@colostate.edu.
Publications dans "Chromatides" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter, Vienna, Austria. michael.mitter@imba.oeaw.ac.at.
Publications dans "Chromatides" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter, Vienna, Austria.
Publications dans "Chromatides" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter, Vienna, Austria.
Publications dans "Chromatides" :
2 publications dans cette catégorie
Affiliations :
Institute of Organic Chemistry and Center for Molecular Biosciences (CMBI), Leopold-Franzens University, Innsbruck, Austria.
Publications dans "Chromatides" :
2 publications dans cette catégorie
Affiliations :
Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Guangdong Key Laboratory for Genome Stability & Disease Prevention, School of Basic Medical Sciences, Shenzhen University Medical School, South China Hospital, Shenzhen 518116. State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.
Publications dans "Chromatides" :
2 publications dans cette catégorie
Affiliations :
Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Guangdong Key Laboratory for Genome Stability & Disease Prevention, School of Basic Medical Sciences, Shenzhen University Medical School, South China Hospital, Shenzhen 518116. State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.
Publications dans "Chromatides" :
2 publications dans cette catégorie
Affiliations :
Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Guangdong Key Laboratory for Genome Stability & Disease Prevention, School of Basic Medical Sciences, Shenzhen University Medical School, South China Hospital, Shenzhen 518116. State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.
Publications dans "Chromatides" :
Cefepime is a broad-spectrum fourth-generation cephalosporin with activity against Gram-positive and Gram-negative pathogens. It is generally administered as an infusion over 30-60 min or as a prolong...
Cefepime is a first-line agent for empiric sepsis therapy; however, cefepime use may be associated with increased mortality for extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) in ...
This single-center retrospective cohort study included patients admitted from October 2010 to August 2020 who received cefepime or meropenem empirically for sepsis with a blood culture growing ceftria...
Fifty-four patients met inclusion criteria: 36 received meropenem and 18 received cefepime. The median (IQR) treatment durations of cefepime and meropenem were 3 (2-6) days and 7 (5-10) days, respecti...
Mortality was similar between groups, although most patients who received cefepime empirically were ultimately transitioned to a carbapenem to complete the full treatment course. Empiric cefepime was ...
Data evaluating cefepime thresholds associated with neurotoxicity remain limited. The objectives of this study were to evaluate the incidence of cefepime-related neurotoxicity (CRN) in patients with p...
This was a retrospective study of adult inpatients admitted between 2016 and 2018 who received cefepime therapeutic drug monitoring (TDM). Potential CRN cases were identified utilizing a standard defi...
Four hundred eighty-one patients with 503 hospital encounters received cefepime TDM and were included in the analysis. The incidence of CRN was 4.4% (22/503). Patients with CRN had a higher incidence ...
Cefepime should be used cautiously in hospitalized patients with renal dysfunction due to the risk of neurotoxicity. Dose optimization utilizing TDM early in cefepime treatment may minimize adverse ef...
A novel sandwich assay for the detection of L. monocytogenes was designed based on antibiotic magnetic separation and enzymatic colorimetry. PEG-mediated cefepime functionalized magnetic nanoparticles...
Cefepime is commonly used in pediatric intensive care units, where unpredictable variations in the patients' pharmacokinetic (PK) variables may require drug dose adjustments. The objectives of the pre...
Children (aged from 1 month to 18 years; body weight >3 kg) receiving cefepime were included. Cefepime total plasma concentrations were measured using high performance liquid chromatography. Data were...
Fifty-nine patients (median (range) age: 13.5 months (1.1 months to 17.6 years)) and 129 cefepime concentration measurements were included. The cefepime concentration data were best fitted by a one-co...
Appropriate cefepime dosing regimens should take renal function into account. Continuous infusions are required in critically ill children with normal or augmented renal clearance, while intermittent ...
Taniborbactam, an investigational β-lactamase inhibitor that is active against both serine- and metallo-β-lactamases, is being developed in combination with cefepime to treat serious infections caused...
Cefepime has been reported to cause concentration-related neurotoxicity, especially in critically ill patients with renal failure. This evaluation aimed to identify a dosing regimen providing a suffic...
Febrile neutropenia (FN) occurs in up to 80% of patients with hematologic malignancies. Evidence suggests using extended infusions (EI) of beta-lactams can improve outcomes in some populations, but th...
Patients with acute myeloid or lymphocytic leukemia who developed FN between April 2014 and January 2021 were included in this single-center, retrospective study. The primary outcome was to compare me...
Overall, 193 patients were included. Baseline characteristics were similar between groups. Time to defervescence was significantly shorter with EI compared with the SI group (median 48 h [48-100.5] vs...
Despite reduced total daily dose of cefepime, EI cefepime administered as a 1G/0.5 h LD followed 2 h later by 1G q8h/4 h for FN acutely achieves more rapid defervescence than the FDA-approved SI regim...
Kaye KS, Belley A, Barth P, et al....
Five Enterobacter cloacae isolates were subjected to 10-day serial passage in broth microdilution with cefepime, meropenem, or ceftazidime-avibactam to evaluate increases in minimum inhibitory concent...